These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
420 related items for PubMed ID: 30151728
1. Treatment of Diabetes in Patients with Heart Failure. Bowes CD, Lien LF, Butler J. Curr Cardiol Rep; 2018 Aug 27; 20(10):97. PubMed ID: 30151728 [Abstract] [Full Text] [Related]
2. Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors. Scheen AJ. Circ Res; 2018 May 11; 122(10):1439-1459. PubMed ID: 29748368 [Abstract] [Full Text] [Related]
15. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Nauck MA, Meier JJ, Cavender MA, Abd El Aziz M, Drucker DJ. Circulation; 2017 Aug 29; 136(9):849-870. PubMed ID: 28847797 [Abstract] [Full Text] [Related]
16. Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes. Libianto R, Davis TM, Ekinci EI. Med J Aust; 2020 Feb 29; 212(3):133-139. PubMed ID: 31910303 [Abstract] [Full Text] [Related]
18. Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists. North EJ, Newman JD. Curr Opin Cardiol; 2019 Nov 29; 34(6):687-692. PubMed ID: 31436559 [Abstract] [Full Text] [Related]
19. Do dipeptidyl peptidase IV (DPP-IV) inhibitors cause heart failure? Clifton P. Clin Ther; 2014 Dec 01; 36(12):2072-2079. PubMed ID: 25453730 [Abstract] [Full Text] [Related]
20. Novel antidiabetic drugs and cardiovascular risk: Primum non nocere. Bonadonna RC, Borghi C, Consoli A, Volpe M. Nutr Metab Cardiovasc Dis; 2016 Sep 01; 26(9):759-66. PubMed ID: 27373139 [Abstract] [Full Text] [Related] Page: [Next] [New Search]